chr14-50429232-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_006575.6(MAP4K5):āc.2193A>Gā(p.Val731=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00286 in 1,564,206 control chromosomes in the GnomAD database, including 104 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.015 ( 53 hom., cov: 32)
Exomes š: 0.0015 ( 51 hom. )
Consequence
MAP4K5
NM_006575.6 synonymous
NM_006575.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.413
Genes affected
MAP4K5 (HGNC:6867): (mitogen-activated protein kinase kinase kinase kinase 5) This gene encodes a member of the serine/threonine protein kinase family, that is highly similar to yeast SPS1/STE20 kinase. Yeast SPS1/STE20 functions near the beginning of the MAP kinase signal cascades that is essential for yeast pheromone response. This kinase was shown to activate Jun kinase in mammalian cells, which suggested a role in stress response. Two alternatively spliced transcript variants encoding the same protein have been described for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 14-50429232-T-C is Benign according to our data. Variant chr14-50429232-T-C is described in ClinVar as [Benign]. Clinvar id is 783688.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.413 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0511 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAP4K5 | NM_006575.6 | c.2193A>G | p.Val731= | synonymous_variant | 29/33 | ENST00000682126.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAP4K5 | ENST00000682126.1 | c.2193A>G | p.Val731= | synonymous_variant | 29/33 | NM_006575.6 | P1 | ||
MAP4K5 | ENST00000013125.9 | c.2193A>G | p.Val731= | synonymous_variant | 29/33 | 1 | P1 | ||
MAP4K5 | ENST00000554990.6 | n.2946A>G | non_coding_transcript_exon_variant | 15/19 | 2 | ||||
MAP4K5 | ENST00000557390.6 | c.*14A>G | 3_prime_UTR_variant, NMD_transcript_variant | 29/33 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0154 AC: 2347AN: 152186Hom.: 53 Cov.: 32
GnomAD3 genomes
AF:
AC:
2347
AN:
152186
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00358 AC: 651AN: 181924Hom.: 14 AF XY: 0.00270 AC XY: 260AN XY: 96270
GnomAD3 exomes
AF:
AC:
651
AN:
181924
Hom.:
AF XY:
AC XY:
260
AN XY:
96270
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00150 AC: 2119AN: 1411902Hom.: 51 Cov.: 28 AF XY: 0.00125 AC XY: 872AN XY: 697850
GnomAD4 exome
AF:
AC:
2119
AN:
1411902
Hom.:
Cov.:
28
AF XY:
AC XY:
872
AN XY:
697850
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0155 AC: 2354AN: 152304Hom.: 53 Cov.: 32 AF XY: 0.0153 AC XY: 1137AN XY: 74488
GnomAD4 genome
AF:
AC:
2354
AN:
152304
Hom.:
Cov.:
32
AF XY:
AC XY:
1137
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3474
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 03, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at